SCHEMBL3673978

SCHEMBL3673978

CC(C)C(O)C(C#N)c1cccc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.40
ADRA2A P08913 5/20 0.38
ADRA2B P18089 5/20 0.38
ADRA2C P18825 5/20 0.38
ADRA1A P35348 4/20 0.38
ADRA1D P25100 3/20 0.38
ADRA1B P35368 3/20 0.38
ALOX5 P09917 1/20 0.38
AOC3 Q16853 1/20 0.37
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11545332 0.86 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A
SCHEMBL11546306 0.77 ALDH1A1 (0.42) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL3684202 0.77 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A
SCHEMBL12238420 0.75 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL1527193 0.75 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL10399086 0.75 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A
SCHEMBL12238419 0.75 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL9014808 0.73 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL6055090 0.73 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A
SCHEMBL1155486 0.73 CYP1A2 (0.56) ALDH1A1CYP1A2CYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168246-A1 AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE RICHELSON ELLIOTT 2010-07-01 US disclosed
US-20080275272-A1 AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE RICHELSON ELLIOTT 2008-11-06 US disclosed
US-20070197662-A1 AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 2007-08-23 US disclosed
US-7214826-B2 Amine compounds and inhibiting neurotransmitter reuptake MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2007-05-08 US disclosed
EP-1414425-A4 AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE MAYO FOUNDATION (US) 2007-04-11 EP disclosed
US-20050215647-A1 Amine compounds and inhibiting neurotransmitter reuptake Mayo Foundation for Medical Education and Research and Virginia Tech Intellectual Properties, Inc. 2005-09-29 US disclosed
US-6914080-B2 Amine compounds and inhibiting neurotransmitter reuptake MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2005-07-05 US disclosed
US-20040143022-A1 Amine compounds and inhibiting neurotransmitter reuptake MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2004-07-22 US disclosed
EP-1414425-A1 AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2004-05-06 EP disclosed
US-6700018-B2 3-HYDROXY-2-(2-NAPHTHYL)PENTYLAMINE DERIVATIVES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2004-03-02 US disclosed
US-20030027869-A1 Amine compounds and inhibiting neurotransmitter reuptake VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 2003-02-06 US disclosed
WO-2003007929-A1 AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2003-01-30 WO disclosed